Skip to content
healthcare.dev
Get a free key

Eribulin Mesylate

NDC 71731-4171, Eribulin Mesylate, injection, from Chia Tai Tianqing Pharmaceutical Group Co., Ltd..

Product NDC
71731-4171
Status
Listed
Labeler
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218743
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71731-4171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
71731-4171-1717314171011 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8a81f3e9-ac52-4f98-bf62-da7974d012b3

Use it

Look up 71731-4171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71731-4171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71731-4171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.